Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MESH: Nuclear Proteins/metabolism"" wg kryterium: Temat


Tytuł :
Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain
Autorzy :
Malki, Idir
Cantrelle, François-Xavier
Sottejeau, Yoann
Lippens, Guy
Lambert, Jean-Charles
Landrieu, Isabelle
Pokaż więcej
Temat :
MESH: Adaptor Proteins, Signal Transducing/chemistry
MESH: Adaptor Proteins, Signal Transducing/genetics
MESH: Kinetics
MESH: Models, Molecular
MESH: Neurons/chemistry
MESH: Neurons/metabolism
MESH: Nuclear Magnetic Resonance, Biomolecular
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/genetics
MESH: Nuclear Proteins/metabolism
MESH: Peptides/chemistry
MESH: Peptides/genetics
MESH: Adaptor Proteins, Signal Transducing/metabolism
MESH: Peptides/metabolism
MESH: Protein Binding
MESH: Protein Conformation, alpha-Helical
MESH: Protein Conformation, beta-Strand
MESH: Protein Interaction Domains and Motifs
MESH: Protein Isoforms/chemistry
MESH: Protein Isoforms/genetics
MESH: Protein Isoforms/metabolism
MESH: Recombinant Proteins/chemistry
MESH: Recombinant Proteins/genetics
MESH: Amino Acid Motifs
MESH: Recombinant Proteins/metabolism
MESH: Sequence Alignment
MESH: Sequence Homology, Amino Acid
MESH: Tumor Suppressor Proteins/chemistry
MESH: Tumor Suppressor Proteins/genetics
MESH: Tumor Suppressor Proteins/metabolism
MESH: tau Proteins/chemistry
MESH: tau Proteins/genetics
MESH: tau Proteins/metabolism
MESH: Binding Sites
MESH: Cloning, Molecular
MESH: Escherichia coli/genetics
MESH: Escherichia coli/metabolism
MESH: Gene Expression
MESH: Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
FEBS Journal, Wiley, 2017, 284 (19), pp.3218 - 3229. ⟨10.1111/febs.14185⟩
Tytuł :
Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain
Autorzy :
Malki, Idir
Cantrelle, François-Xavier
Sottejeau, Yoann
Lippens, Guy
Lambert, Jean-Charles
Landrieu, Isabelle
Pokaż więcej
Temat :
MESH: Adaptor Proteins, Signal Transducing/chemistry
MESH: Adaptor Proteins, Signal Transducing/genetics
MESH: Kinetics
MESH: Models, Molecular
MESH: Neurons/chemistry
MESH: Neurons/metabolism
MESH: Nuclear Magnetic Resonance, Biomolecular
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/genetics
MESH: Nuclear Proteins/metabolism
MESH: Peptides/chemistry
MESH: Peptides/genetics
MESH: Adaptor Proteins, Signal Transducing/metabolism
MESH: Peptides/metabolism
MESH: Protein Binding
MESH: Protein Conformation, alpha-Helical
MESH: Protein Conformation, beta-Strand
MESH: Protein Interaction Domains and Motifs
MESH: Protein Isoforms/chemistry
MESH: Protein Isoforms/genetics
MESH: Protein Isoforms/metabolism
MESH: Recombinant Proteins/chemistry
MESH: Recombinant Proteins/genetics
MESH: Amino Acid Motifs
MESH: Recombinant Proteins/metabolism
MESH: Sequence Alignment
MESH: Sequence Homology, Amino Acid
MESH: Tumor Suppressor Proteins/chemistry
MESH: Tumor Suppressor Proteins/genetics
MESH: Tumor Suppressor Proteins/metabolism
MESH: tau Proteins/chemistry
MESH: tau Proteins/genetics
MESH: tau Proteins/metabolism
MESH: Binding Sites
MESH: Cloning, Molecular
MESH: Escherichia coli/genetics
MESH: Escherichia coli/metabolism
MESH: Gene Expression
MESH: Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
FEBS Journal, Wiley, 2017, 284 (19), pp.3218 - 3229. ⟨10.1111/febs.14185⟩
Tytuł :
Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain
Autorzy :
Malki, Idir
Cantrelle, François-Xavier
Sottejeau, Yoann
Lippens, Guy
Lambert, Jean-Charles
Landrieu, Isabelle
Pokaż więcej
Temat :
MESH: Adaptor Proteins, Signal Transducing/chemistry
MESH: Adaptor Proteins, Signal Transducing/genetics
MESH: Kinetics
MESH: Models, Molecular
MESH: Neurons/chemistry
MESH: Neurons/metabolism
MESH: Nuclear Magnetic Resonance, Biomolecular
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/genetics
MESH: Nuclear Proteins/metabolism
MESH: Peptides/chemistry
MESH: Peptides/genetics
MESH: Adaptor Proteins, Signal Transducing/metabolism
MESH: Peptides/metabolism
MESH: Protein Binding
MESH: Protein Conformation, alpha-Helical
MESH: Protein Conformation, beta-Strand
MESH: Protein Interaction Domains and Motifs
MESH: Protein Isoforms/chemistry
MESH: Protein Isoforms/genetics
MESH: Protein Isoforms/metabolism
MESH: Recombinant Proteins/chemistry
MESH: Recombinant Proteins/genetics
MESH: Amino Acid Motifs
MESH: Recombinant Proteins/metabolism
MESH: Sequence Alignment
MESH: Sequence Homology, Amino Acid
MESH: Tumor Suppressor Proteins/chemistry
MESH: Tumor Suppressor Proteins/genetics
MESH: Tumor Suppressor Proteins/metabolism
MESH: tau Proteins/chemistry
MESH: tau Proteins/genetics
MESH: tau Proteins/metabolism
MESH: Binding Sites
MESH: Cloning, Molecular
MESH: Escherichia coli/genetics
MESH: Escherichia coli/metabolism
MESH: Gene Expression
MESH: Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
FEBS Journal, Wiley, 2017, 284 (19), pp.3218 - 3229. ⟨10.1111/febs.14185⟩
Tytuł :
Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain
Autorzy :
Malki, Idir
Cantrelle, François-Xavier
Sottejeau, Yoann
Lippens, Guy
Lambert, Jean-Charles
Landrieu, Isabelle
Pokaż więcej
Temat :
MESH: Kinetics
MESH: Protein Isoforms/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Tumor Suppressor Proteins/chemistry
MESH: Protein Conformation, beta-Strand
MESH: tau Proteins/metabolism
MESH: Adaptor Proteins, Signal Transducing/metabolism
MESH: Recombinant Proteins/chemistry
MESH: Binding Sites
MESH: Nuclear Magnetic Resonance, Biomolecular
MESH: Adaptor Proteins, Signal Transducing/chemistry
MESH: Recombinant Proteins/genetics
MESH: tau Proteins/genetics
MESH: Neurons/metabolism
MESH: Nuclear Proteins/chemistry
MESH: Peptides/chemistry
MESH: Cloning, Molecular
MESH: Protein Interaction Domains and Motifs
MESH: Neurons/chemistry
MESH: Sequence Homology, Amino Acid
MESH: Tumor Suppressor Proteins/metabolism
MESH: Protein Conformation, alpha-Helical
MESH: Protein Isoforms/metabolism
MESH: Peptides/genetics
MESH: Humans
MESH: Protein Isoforms/genetics
MESH: Tumor Suppressor Proteins/genetics
MESH: Gene Expression
MESH: Models, Molecular
MESH: Escherichia coli/metabolism
MESH: Nuclear Proteins/genetics
MESH: Protein Binding
MESH: Escherichia coli/genetics
MESH: Amino Acid Motifs
MESH: Recombinant Proteins/metabolism
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH: Adaptor Proteins, Signal Transducing/genetics
MESH: Peptides/metabolism
MESH: tau Proteins/chemistry
MESH: Sequence Alignment
Źródło :
FEBS Journal, Wiley, 2017, 284 (19), pp.3218 - 3229. ⟨10.1111/febs.14185⟩
Tytuł :
Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain
Autorzy :
Malki, Idir
Cantrelle, François-Xavier
Sottejeau, Yoann
Lippens, Guy
Lambert, Jean-Charles
Landrieu, Isabelle
Pokaż więcej
Temat :
MESH: Adaptor Proteins, Signal Transducing/chemistry
MESH: Adaptor Proteins, Signal Transducing/genetics
MESH: Kinetics
MESH: Models, Molecular
MESH: Neurons/chemistry
MESH: Neurons/metabolism
MESH: Nuclear Magnetic Resonance, Biomolecular
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/genetics
MESH: Nuclear Proteins/metabolism
MESH: Peptides/chemistry
MESH: Peptides/genetics
MESH: Adaptor Proteins, Signal Transducing/metabolism
MESH: Peptides/metabolism
MESH: Protein Binding
MESH: Protein Conformation, alpha-Helical
MESH: Protein Conformation, beta-Strand
MESH: Protein Interaction Domains and Motifs
MESH: Protein Isoforms/chemistry
MESH: Protein Isoforms/genetics
MESH: Protein Isoforms/metabolism
MESH: Recombinant Proteins/chemistry
MESH: Recombinant Proteins/genetics
MESH: Amino Acid Motifs
MESH: Recombinant Proteins/metabolism
MESH: Sequence Alignment
MESH: Sequence Homology, Amino Acid
MESH: Tumor Suppressor Proteins/chemistry
MESH: Tumor Suppressor Proteins/genetics
MESH: Tumor Suppressor Proteins/metabolism
MESH: tau Proteins/chemistry
MESH: tau Proteins/genetics
MESH: tau Proteins/metabolism
MESH: Binding Sites
MESH: Cloning, Molecular
MESH: Escherichia coli/genetics
MESH: Escherichia coli/metabolism
MESH: Gene Expression
MESH: Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
FEBS Journal, Wiley, 2017, 284 (19), pp.3218 - 3229. ⟨10.1111/febs.14185⟩
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre-Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
MESH: Drug Design
MESH : Enzyme Inhibitors/pharmacology
MESH : Antineoplastic Agents/metabolism
MESH : Enzyme Inhibitors/metabolism
MESH : Antineoplastic Agents/pharmacology
MESH : Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Nuclear Proteins/metabolism
MESH : Animals
MESH : Nuclear Proteins/metabolism
MESH: Proto-Oncogene Proteins/chemistry
MESH: Nuclear Proteins/antagonists & inhibitors
MESH : Cell Line, Tumor
Inhibitor
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH: Nuclear Proteins/chemistry
MESH : Protein Conformation
MESH : Antineoplastic Agents/chemical synthesis
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/metabolism
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Rats
MESH: Molecular Targeted Therapy
MESH : Molecular Docking Simulation
MESH : Proto-Oncogene Proteins/chemistry
MESH : Enzyme Inhibitors/chemical synthesis
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Purine Nucleotides/chemical synthesis
MESH: Chemistry Techniques, Synthetic
MESH : Chemistry Techniques, Synthetic
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH : Humans
MESH: Antineoplastic Agents/chemistry
MESH: Purine Nucleotides/pharmacology
MESH : Drug Screening Assays, Antitumor
MESH : Purine Nucleotides/pharmacology
MESH: Cell Line, Tumor
MESH: Molecular Docking Simulation
MESH: Animals
MESH : Antineoplastic Agents/chemistry
MESH : Nuclear Proteins/chemistry
MESH: Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemistry
MESH : Enzyme Inhibitors/chemistry
MESH : Proto-Oncogene Proteins/metabolism
Nucleoside analogues
MESH : Purine Nucleotides/metabolism
MESH : Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemical synthesis
DNPH1
MESH: Enzyme Inhibitors/metabolism
MESH: Protein Conformation
MESH : Drug Design
MESH: Proto-Oncogene Proteins/metabolism
Cross-coupling reaction
MESH: Enzyme Inhibitors/pharmacology
MESH : Purine Nucleotides/chemical synthesis
MESH: Humans
MESH: Purine Nucleotides/metabolism
MESH: Antineoplastic Agents/pharmacology
MESH : Molecular Targeted Therapy
MESH : N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/chemistry
MESH : Rats
MESH : N-Glycosyl Hydrolases/metabolism
MESH: Antineoplastic Agents/chemical synthesis
MESH : N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Drug Screening Assays, Antitumor
Crystal structure
Cancer
MESH: Structure-Activity Relationship
MESH : Nuclear Proteins/antagonists & inhibitors
MESH : Structure-Activity Relationship
Źródło :
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. 〈10.1016/j.ejmech.2014.07.110〉
European Journal of Medicinal Chemistry
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies